Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.83 is 88% above its 5-year average of -22.86, near the high end of its 5-year range (-113.06–1.01).
9.22% above its 12-month average of -3.12.
Reported quarterly EPS; no daily interpolation. Q1 FY2026 (2026-03-31): 0.02.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 13 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:51:10.184Z. Historical observations retain their original dates. Historical series through 2023-08-14.
EARNINGS PER SHARE (EPS)
-2.83
EARNINGS PER SHARE (EPS) AVG TTM
-3.12
EARNINGS PER SHARE (EPS) AVG 3Y
-4.06
EARNINGS PER SHARE (EPS) AVG 5Y
-22.86
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+9.22%
CURRENT VS 3Y AVG
+30.30%
CURRENT VS 5Y AVG
+87.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Celularity Inc.
Market Cap
$45.73M
Earnings Per Share (EPS)
-2.83
TTM Avg
-3.12
3Y Avg
-4.06
5Y Avg
-22.86
Market Cap
$46.69M
Earnings Per Share (EPS)
-4.47
TTM Avg
-11.04
3Y Avg
-20.14
5Y Avg
-19.34
Market Cap
$44.72M
Earnings Per Share (EPS)
-0.73
TTM Avg
-1.48
3Y Avg
-1.47
5Y Avg
-1.37
Market Cap
$44.71M
Earnings Per Share (EPS)
0.90
TTM Avg
-2.83
3Y Avg
-6.22
5Y Avg
-12.54
Market Cap
$44.02M
Earnings Per Share (EPS)
0.69
TTM Avg
-0.78
3Y Avg
-1.53
5Y Avg
-2.71
Market Cap
$47.98M
Earnings Per Share (EPS)
-9.11
TTM Avg
-2.23
3Y Avg
-1.64
5Y Avg
-3.32
Market Cap
$42.99M
Earnings Per Share (EPS)
-1.98
TTM Avg
-2.34
3Y Avg
-2.17
5Y Avg
-1.92
Market Cap
$48.53M
Earnings Per Share (EPS)
N/A
TTM Avg
-30.18
3Y Avg
-88.49
5Y Avg
-66.35
Market Cap
$42.83M
Earnings Per Share (EPS)
-1.70
TTM Avg
-1.03
3Y Avg
-1.29
5Y Avg
-1.28
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celularity Inc. (CELU) | $45.73M | -2.83 | -3.12 | -4.06 | -22.86 |
| Instil Bio, Inc. (TIL)vs › | $46.69M | -4.47 | -11.04 | -20.14 | -19.34 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | -0.73 | -1.48 | -1.47 | -1.37 |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 0.90 | -2.83 | -6.22 | -12.54 |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 0.69 | -0.78 | -1.53 | -2.71 |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | -9.11 | -2.23 | -1.64 | -3.32 |
| CVRx, Inc. (CVRX)vs › | $42.99M | -1.98 | -2.34 | -2.17 | -1.92 |
| Apollomics, Inc. (APLM)vs › | $48.53M | N/A | -30.18 | -88.49 | -66.35 |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -1.70 | -1.03 | -1.29 | -1.28 |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | -1.11 | -1.06 | -1.20 | -1.30 |
Trailing EPS (TTM)
$-2.83
Forward EPS (Est.)
$-2.75
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.59 |
| 2024-12-31 | -2.64 |
| 2023-12-31 | -11.02 |
| 2022-12-31 | 1.01 |
| 2021-12-31 | -7.87 |
| 2020-12-31 | -113.06 |
| 2019-12-31 | -88.75 |
| 2018-12-31 | 0.00 |
